CMLD012072 is primarily investigated for its potential in cancer therapy, particularly in targeting specific pathways involved in tumor growth and proliferation. It has shown promise in preclinical studies as an inhibitor of certain kinases that play a critical role in cancer cell survival and metastasis. Researchers are exploring its efficacy in treating various types of cancers, including breast, lung, and colorectal cancers. Additionally, its ability to enhance the effectiveness of existing chemotherapy drugs is being studied, potentially reducing the required dosage and minimizing side effects. Further research is ongoing to evaluate its safety, pharmacokinetics, and potential for clinical use.